KPT-185
CAS No. 1333151-73-7
KPT-185( —— )
Catalog No. M11326 CAS No. 1333151-73-7
KPT-185 is a selective CRM1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 25MG | 96 | In Stock |
|
| 50MG | 162 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKPT-185
-
NoteResearch use only, not for human use.
-
Brief DescriptionKPT-185 is a selective CRM1 inhibitor.
-
DescriptionKPT-185 is a selective CRM1 inhibitor.
-
In VitroCell Viability Assay Cell Line:HPB-ALL, Jurkat, CCRF-CEM, MOLT-4, KOPTK1, LOUCY cells Concentration:1, 10, 100, 1000 nM Incubation Time:72 hours Result:The growth of those lines was dramatically reduced with IC50s of 16–395 nM after 72 h of exposure.
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetCRM1
-
RecptorCRM1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1333151-73-7
-
Formula Weight355.31
-
Molecular FormulaC16H16F3N3O3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 71 mg/mL (199.82 mM); DMSO: 71 mg/mL (199.82 mM)
-
SMILESCC(C)OC(=O)/C=C\N1C=NC(=N1)C2=CC(=CC(=C2)OC)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ranganathan P, et al. Blood. 2012, 120(9), 1765-1773.
molnova catalog
related products
-
KPT276
KPT-276 is an orally bioavailable selective inhibitor of nuclear export (SINE) that irreversibly bind to CRM1 and block the function of CRM1.
-
CBS9106
CBS9106 (SL-801) is a reversible oral CRM1 inhibitor with CRM1 degrading and antitumor activity.
-
Leptomycin B
Leptomycin B is a potent inhibitor of the nuclear export of proteins and is a potent antifungal antibiotic blocking the eukaryotic cell cycle. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue.
Cart
sales@molnova.com